Related Experiment Video

Updated: Jun 1, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Role of TGF-β in melanoma

A Busse1, U Keilholz

  • 1Dept. of Medicine III, Charité, Campus Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, Germany. antonia.busse@charite.de

Current Pharmaceutical Biotechnology
|May 31, 2011
PubMed

Insights

Transforming growth factor-beta (TGF-β) is crucial in melanoma progression, promoting tumor growth and immune evasion. Targeting TGF-β pathways offers a promising therapeutic strategy for this therapy-resistant cancer.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Human malignant melanoma exhibits resistance to conventional therapies.
  • Transforming growth factor-beta (TGF-β) plays a significant role in melanoma progression.
  • Cutaneous melanoma often shows resistance to TGF-β's growth inhibitory effects without pathway alterations.

Purpose of the Study:

  • To review current knowledge on TGF-β in melanoma.
  • To discuss therapeutic approaches targeting the TGF-β pathway in melanoma.

Main Methods:

  • Literature review of TGF-β's role in melanoma.
  • Analysis of TGF-β signaling pathways in melanoma progression.
  • Discussion of emerging therapeutic strategies targeting TGF-β.

Main Results:

  • Melanoma progression correlates with increased TGF-β production.
  • TGF-β promotes tumor growth by inhibiting immune responses and enhancing motility/invasiveness.
  • TGF-β signaling impacts angiogenesis and immune surveillance.

Conclusions:

  • Understanding TGF-β's diverse signaling pathways is key to identifying therapeutic targets.
  • Targeting TGF-β pathways presents a promising avenue for treating melanoma.
  • Further research into TGF-β's context-dependent effects is warranted for effective therapeutic development.

More Related Videos

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...